INTRODUCTION
============

Traveler's diarrhea (TD) is the most common and persistent travel-related disease \[[@b1-kjp-54-5-631],[@b2-kjp-54-5-631]\]. TD pathogens are well known for causing an urgent loose stool, severe abdominal pain, vomiting, chills, and fever \[[@b1-kjp-54-5-631],[@b3-kjp-54-5-631]\]. According to the CDC's Health Information for International Travel 2016, the attack rates of TD ranged from 30% to 70% of travelers, depending on the destination and season \[[@b4-kjp-54-5-631]\]. In addition, the GeoSentinel database from which travel-related morbidity is recorded reported 335 diarrhea cases per 1,000 medical visits after traveling \[[@b5-kjp-54-5-631]\]. In general, enterotoxigenic *Escherichia coli* (ETEC), enteroaggregative *E. coli* (EAEC), *Salmonella* species, *Shigella* species, *Aeromonas* species, and *Campylobacter jejuni* are considered the major bacterial pathogens that can elicit TD \[[@b1-kjp-54-5-631]\]. Moreover, viruses causing gastroenteritis (e.g., noroviruses and rotavirus), as well as waterborne protozoan parasites (e.g., *Cryptosporidium parvum, Giardia lamblia, Cyclospora cayetanensis*, and *Entamoeba histolytica*), are also important TD pathogens \[[@b1-kjp-54-5-631]\]. In particular, waterborne protozoan parasites have been reported as the causes of endemic outbreaks in some countries \[[@b6-kjp-54-5-631]\]. Because the risk for cyclosporiasis has been increasing in some regions \[[@b1-kjp-54-5-631],[@b7-kjp-54-5-631],[@b8-kjp-54-5-631]\], *C. parvum*, *G. lamblia*, and *C. cayetanensis* have attracted attention as the cause of TD when travelers to developing countries cannot be cured by the standard antimicrobial treatments for their diarrhea \[[@b1-kjp-54-5-631]\].

However, there are few existing rapid diagnostic tools that can save time and effort by simultaneously detecting such protozoan parasites. This study aimed to develop a simultaneous multiplex PCR method for detecting 3 species of waterborne protozoan parasites (*C. parvum*, *G. lamblia*, and *C. cayetanensis*) causing TD accompanied by diarrhea that persists for longer than 2 weeks. For this purpose, we used the genomic DNA of these parasites, as well as the gene targets; *Cryptosporidium* oocyst wall protein (COWP) gene for *C. parvum*, the glutamate dehydrogenase (*gdh*) gene for *G. lamblia*, and the 18S ribosomal RNA (18S rRNA) gene for *C. cayetanensis* were selected by a preliminary in silico analysis. Here, we report the development of a successful protocol to avoid mispriming and non-specific binding among primer pairs using a touchdown PCR method \[[@b9-kjp-54-5-631]\]. In addition, we investigated the limit of detection (LOD) for a mixture of primers and optimized the PCR conditions for the detection of each parasite in protozoa-spiked human stool samples.

MATERIALS AND METHODS
=====================

DNA preparation
---------------

For the preparation of the genomic DNA, *C. parvum* oocysts were purchased from Waterborne^™^, Inc. (New Orleans, Louisiana, USA) and *G. lamblia* cysts were kindly provided by the Division of Malaria and Parasitic Diseases, Korea National Research Institute of Health, Korea Center for Disease Control and Prevention, Osong, Korea. *C. cayetanenesis* was purchased from ATCC as synthetic DNA, including the full 18S rRNA, internal transcribed spacer 1 (ITS1), and internal transcribed spacer 2 (ITS2) (ATCC® PRA-3000SD^™^, Manassas, Virginia, USA). Genomic DNA for 1×10^6^ oocysts/cysts of *C. parvum* and *G. lamblia* were extracted using a DNeasy blood and tissue kit (Qiagen, Hilden, Germany) with a repeated freezing and thawing process (6 cycles of 95°C for 1 min and liquid nitrogen for 30 sec). Finally, the purified DNA was eluted by 20 μl of AE buffer using a mini spin column (Qiagen) and stored at −20°C. The purity and concentration of the DNA were measured using Nanodrop 2000 (Thermo Scientific, Wilmington, Delaware, USA).

DNA extraction from oocysts and the cyst-spiked human stool sample
------------------------------------------------------------------

Stool samples were obtained from health screening participants according to the Ethics Committee of the Inha University Hospital IRB approved protocol (Research 15-026) and provided for the preparation of the oocysts and cyst-spiked stool sample. *C. parvum* oocysts were decimally diluted in PBS to obtain a dilution series containing 1×10^7^--1×10^3^ and seeded into 200 mg of uninfected human stool samples. Protozoan parasites were not found in these stool samples using standard detection tests comprising microscopy and conventional nested PCR \[[@b10-kjp-54-5-631],[@b11-kjp-54-5-631]\]. Likewise, human stool samples containing *G. lamblia* cysts were prepared using the method described above. Genomic DNA in the *C. parvum* or *G. lamblia*-spiked stool sample was extracted using the AccuPrep® Stool DNA extraction kit (Bioneer, Daejeon, Korea) according to the manufacturer's protocol with a repeated freezing and thawing process (6 cycles at 95°C for 1 min and liquid nitrogen for 30 sec) to make it easier to break the cyst wall. Finally, the total genomic DNA was eluted by 20 μl of elution buffer (Bioneer), and 2 μl was used for the PCR reaction. In the case of *C. cayetanensis*, we used synthetic DNA purchased from ATCC because it was difficult to obtain the necessary amount of cysts required for this experiment. After 1×10^6^ copies of synthetic DNA (ATCC) were serially diluted to 10^−1^ copies, 1 μl of the diluted DNA, which contains each copy number from 1×10^6^ to 1×10^−1^, and 2 μl of the stool genomic DNA extracted from 200 mg of an uninfected stool sample were mixed and applied to the PCR reaction as a template. Although the copy number of the 18S rRNA in *C. cayetanensis* has not been elucidated, it can be predicted to be greater than 100 copies when it is compared to that of other protozoa with similar phylogenetic features \[[@b12-kjp-54-5-631],[@b13-kjp-54-5-631]\].

Primer design
-------------

Diagnostic PCR primers were designed to amplify the specifically targeted gene segments for each parasite ([Table 1](#t1-kjp-54-5-631){ref-type="table"}). All primers were newly designed in the present study. Briefly, the primers for *C. parvum* were developed with some modifications based on previously reported primers, cry-9 and cry-15, targeted to the *Cryptosporidium* oocyst wall protein (COWP) \[[@b14-kjp-54-5-631]\]. In contrast, the primers for *G. lamblia* and *C. cayetanensis* were created using Geneious version R8 software (Biomatters Ltd., Auckland, New Zealand) for GDH and the 18S rRNA, respectively. Primer synthesis and sequencing for amplicon were performed by Macrogen Inc. (Seoul, Korea).

Multiplex-touchdown PCR amplification
-------------------------------------

Multiplex-touchdown PCR was performed using Surecycler 8800 (Agilent Technologies, Santa Clara, California, USA), and the PCR conditions were performed as follows. The DNA templates (1--3 μl), 15 μl of 2×PCR premix (2×Taq PCR Pre-Mix, Solgent Co., Daejeon, Korea), and 5 μl of the primer mixture (consisting of 10 pmol primers in each parasite) was mixed with HPLC-grade distilled water (Wako Pure Chemical, Osaka, Japan) to a total volume of 30 μl. The PCR reaction for the negative control was reacted with only the primer, without protozoan DNA. At this time, the specificity and sensitivity of each primer were previously tested and confirmed using a single PCR amplification (data not shown). The multiplex-touchdown PCR amplification protocol consisted of 5 min at 95°C for pre-denaturation, 20 cycles of denaturing at 95°C for 30 sec, annealing at 65°C (with 0.2°C decrements from 65°C to 61.2°C at every cycle) for 40 sec, and extension at 72°C for 1 min. This was followed by a further 25 cycles of denaturing at 95°C for 30 sec, annealing at 61.2°C for 40 sec, and extension at 72°C for 1 min. The reaction was finished with a final extension for 5 min at 72°C. The PCR products were confirmed by the StaySafe Nucleic Acid Gel Stain (Real Biotech Corporation, Taipei, Taiwan) and photographed with UV transillumination using the DNR MiniLumi (DNR Bio-Imaging Systems, Jerusalem, Israel) gel documentation system after loading on 2% agarose (Duchefa, Haarlem, The Netherlands)-TAE gels.

RESULTS
=======

Target specificity of primers and multiplex-touchdown PCR protocol
------------------------------------------------------------------

The amplicon size for each parasite was 555 bp for *C. parvum*, 188 bp for *G. lamblia*, and 400 bp for *C. cayetanensis* ([Fig. 1](#f1-kjp-54-5-631){ref-type="fig"}). The single PCR products were confirmed by analyzing the DNA sequences. Each amplicon exhibited a 100% similarity to AB089292 (*C. parvum*), KJ499992 (*G. lamblia*), and AB111183 (*C. cayetanensis*) in the GenBank database (<http://www.ncbi.nlm.nih.gov>) (data not shown). In every reaction, the primers (a primer mixture containing all 3 types of primers) did not show any cross-reactivity in the parasite-free stools or other protozoan parasites (i.e., *E. histolytica, Toxoplasma gondii*, and *Babesia microti*), which was previously screened for specificity (data not shown). In [Fig. 1](#f1-kjp-54-5-631){ref-type="fig"}, the primer mixture was reacted with each target for monoplex PCR (lanes 2--4), 2 types of targets for duplex PCR (lanes 5--7), and all 3 kinds of targets for triplex PCR (lane 8). The amount of template DNA used for each PCR reaction corresponds to 2 μl of the 20 μl total DNA solution extracted from 1×10^6^ oocysts and cysts of *C. parvum* or *G. lamblia*, and 1 μl of the *C. cayetanensis* synthetic DNA (equivalent to 10^3^ copies). Our results show that the multiplex PCR protocol using the touchdown PCR method did not result in cross-reactivity between the primers or template DNA in the mixed condition of primers and template DNA. In addition, we suggest that the PCR protocol developed in this study makes it possible to improve the specificity of PCR amplification ([Fig. 1](#f1-kjp-54-5-631){ref-type="fig"}).

Limit of detection of each parasite in parasite-spiked human stool samples
--------------------------------------------------------------------------

To investigate the LOD of these protozoa for clinical diagnosis, *C. parvum*- and *G. lamblia*-spiked stool samples (which include between 1×10^7^ and 1×10^3^ oocysts and cysts, respectively) were prepared, and their genomic DNA were used as a template for further PCR reactions. Moreover, 1 μl of synthetic *C. cayetanensis* DNA, which was diluted from 1×10^6^ to 1×10^−1^ copies, and 1 μl of the uninfected stool genomic DNA (100 ng/μl) were mixed and used as a template for the PCR reaction. To investigate the specificity and cross-reactivity of the primers, a primer mixture was used in every reaction ([Fig. 2A--C](#f2-kjp-54-5-631){ref-type="fig"}). Our results indicated that the LOD of *C. parvum* was higher than 1×10^3^ oocysts ([Fig. 2A](#f2-kjp-54-5-631){ref-type="fig"}), and the LOD of *G. lamblia* was greater than 1×10^4^ cysts ([Fig. 2B](#f2-kjp-54-5-631){ref-type="fig"}). Additionally, the LOD of *C. cayetanensis* was higher than 1×10^0^ copies in the stool DNA ([Fig. 2C](#f2-kjp-54-5-631){ref-type="fig"}). This result suggests that the primer consisting of a ribosomal DNA with a high copy number developed for *C. cayetanensis* is highly sensitive compared to that of *C. parvum* and *G. lamblia*, considering the differences in the species of protozoa and the characteristics of the target DNA.

DISCUSSION
==========

TD is a major public health concern that can result in significant morbidity and disability \[[@b2-kjp-54-5-631]\]. A common cause of TD is enteric bacterial infections; however, waterborne protozoa are also a globally important cause of TD because they are easily transmitted through water and food \[[@b1-kjp-54-5-631],[@b14-kjp-54-5-631],[@b15-kjp-54-5-631]\]. Furthermore, it is important to develop a conventional and rapid detection method for clinical applications because TD caused by *C. parvum*, *G. lamblia*, and *C. cayetanensis* are resistant to standard antimicrobial treatment \[[@b1-kjp-54-5-631],[@b16-kjp-54-5-631]\]. Given these issues, this study aimed to develop a new specific multiplex PCR method applicable to fecal samples.

There are several different methods to detect waterborne protozoa, including microscopic examination, PCR-based techniques, fluorescence in situ hybridization, and immunology-based methods \[[@b17-kjp-54-5-631]\]. Among them, PCR is the most common method for molecular detection, and its results are more sensitive than microscopic observations in detecting the parasite \[[@b18-kjp-54-5-631]\]. In particular, the multiplex PCR method has been developed for targeting enteric protozoa (e.g., *C. parvum*, *G. lamblia*, and *E. histolytica*) \[[@b19-kjp-54-5-631]--[@b21-kjp-54-5-631]\]. However, *Cyclospora* infections have recently been increasing in association with poverty and areas of poor sanitation, with fecal-contaminated soil creating an important transmission vehicle for *Cyclospora* \[[@b6-kjp-54-5-631],[@b22-kjp-54-5-631]\]. *C. cayetanensis* infection in patients with TD has been reported in individuals who live in, or have visited different areas of the United States, Caribbean Islands, Central America, South Asia, Eastern Europe, Morocco, and Nepal \[[@b23-kjp-54-5-631]\]. In this situation, the laboratory diagnosis of the infection must be followed for the rapid resolution of symptoms. Similar to *C. parvum* and *G. lamblia*, a reliable detection method for *C. cayetanensis* was developed using a specific PCR assay \[[@b24-kjp-54-5-631]\]. However, we have undertaken the additional challenge of effectively identifying multiple outbreaks of water and foodborne protozoa infections by developing a simultaneous multiplex detection method. For this purpose, we designed a novel multiplex PCR method for the simultaneous detection of *C. parvum*, *G. lamblia*, and *C. cayetanenesis* as potent pathogenic protozoa causing TD. Firstly, we tested several target genes of these protozoa via an in silico analysis using Geneious software to ensure the specific amplification and avoidance of cross-reactivity with other protozoan parasites or enteric bacterial pathogens. As the result, COWP, gdh, and 18S rRNA were selected for *C. parvum*, *G. lamblia*, and *C. cayetanenesis*, respectively. These genes are commonly used for classifying species and identifying parasite isolates using molecular analyses \[[@b13-kjp-54-5-631],[@b25-kjp-54-5-631],[@b26-kjp-54-5-631]\]. The specificity of the primers developed in the present study was demonstrated by the specific amplification of single, duplex, and triplex PCR. Furthermore, the amplified gene fragments exhibited a 100% identity in comparison with the query sequences in BLAST. In particular, the protocol adopted herein consists of touchdown PCR, which circumvents spurious priming during gene amplification \[[@b8-kjp-54-5-631]\], and thus, there is no non-specific amplification of any other microbial DNA in the stool samples.

In this study, the LOD for PCR amplification was more than 1×10^3^ oocysts in *C. parvum* and more than 1×10^4^ cysts in *G. lamblia* in 200 mg of the stool samples required by a routine Stool DNA extraction kit. The detectable number of oocysts from symptomatic individuals has been reported to be 1×10^5^--1×10^7^ oocysts per gram of feces in *C. parvum* \[[@b27-kjp-54-5-631]\], and the infection level may be detectable using our PCR method. In contrast, the LOD to *G. lamblia* was higher than the results obtained using a multicopy rRNA gene, in which the confirmation in the agarose gel was observed for a minimum of 2,000 trophozoites \[[@b28-kjp-54-5-631]\]. The problem in LOD using the *gdh* gene but not the multicopy rRNA gene can be overcome by the characteristics of the *gdh* gene, which is more sensitive and specific than the triose phosphate isomerase gene used prevalently for *G. lamblia* detection \[[@b29-kjp-54-5-631]\]. Above all, our choice to use the *gdh* gene is related to the use of the 18S rRNA gene, a multicopy rRNA, for *C. cayetanenesis* to induce the difference in the amplicon size for the purpose of multiplex PCR development. In general, the PCR target for *C. cayetanenesis* was primarily an rRNA gene, such as ITS or 18S \[[@b25-kjp-54-5-631],[@b30-kjp-54-5-631]\]. In addition, our preliminary data revealed that the *C. cayetanenesis* 18s rRNA was adequate for the multiplex PCR design because of the size difference and specificity in relation to *C. parvum* and *G. lamblia* (data not shown). The LOD of *C. cayetanenesis* was determined for the lowest amount (≥10 copies) of DNA that could be amplified using this system.

Taken together, our protocol has convincingly demonstrated the ability to simultaneously diagnose multiple protozoa in stool samples. Although future studies are required to further evaluate the sensitivity of using clinical samples, ours is the first attempted PCR-based method for the simultaneous detection of *C. parvum*, *G. lamblia*, and *C. cayetanensis*.
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![PCR products amplified using a primer mixture (CP-MT-F, CP-MT-R, GL-MT-F, GL-MT-R, CC-MT-F, and CC-MT-R). Lane 1, 100-bp marker; lanes 2 to 4, single PCR products \[*C. parvum* (555 bp, lane 2), *G. lamblia* (188 bp, lane 3), and *C. cayetanensis* (400 bp, lane 4)\]; lanes 5 to 7, duplex PCR products \[*C. parvum*+*G. lamblia* (lane 5), *C. parvum*+*C. cayetanensis* (lane 6)\], and *G. lamblia*+*C. cayetanensis* (lane 7)\]; Lane 8, triplex PCR (*C. parvum*+*G. lamblia*+*C. cayetanensis*).](kjp-54-5-631f1){#f1-kjp-54-5-631}

![Limit of Detection (LOD) of each parasite in parasite-spiked human stool samples. To investigate the LOD of each parasite when the primer mixture is applied to the human stool samples, *C. parvum*, *G. lamblia*, and *C. cayetanensis*-spiked human stool samples were prepared as described in the "Materials and Methods" section. (A) Lane 1, 100 bp marker; lanes 2 to 6, stool DNA samples containing serially diluted (10^7^ to 10^3^) *C. parvum* oocysts; lane 7, the results of triplex PCR (a mixture of the target DNA). (B) Lane 1, 100 bp marker; lanes 2 to 6, stool DNA samples containing 10^7^ to 10^3^ serially diluted *G. lamblia* cysts; lane 7, the results of the triplex PCR (a mixture of target DNAs). (C) lane 1, 100 bp marker; lanes 2 to 9, *Cyclospora*-negative stool DNA samples mixed with serially diluted quantitative synthetic *Cyclospora cayetanensis* DNA (ATCC, PRA-3000SD™) in copy numbers ranging from 10^6^ to 10^−1^; lane 10, the result of triplex PCR (a mixture of target DNAs). The LOD was investigated by a common multiplex-touchdown PCR protocol using a primer mixture.](kjp-54-5-631f2){#f2-kjp-54-5-631}

###### 

Information regarding the primers used for simultaneous multiplex-touchdown PCR of *C. parvum*, *G. lamblia*, and *C. cayetanensis*

  Target organism             Primer name   Direction                                                                Sequence (5′-3′)                     Target                                         GenBank accession no.   Product length (bp)
  --------------------------- ------------- ------------------------------------------------------------------------ ------------------------------------ ---------------------------------------------- ----------------------- ---------------------
  *Cryptosporidium parvum*    CP-MT-F       Forward                                                                  TCG TAG ATA ATG GAA GAG ATT GTG TT   *Cryptosporidium* oocyst wall protein (COWP)   AB089292                555
  CP-MT-R                     Reverse       GGA CTG AAA TAC AGG CAT TAT CTT G                                                                                                                                                    
                                                                                                                                                                                                                                 
  *Giardia lamblia*           GL-MT-F       Forward                                                                  CTC CGC TTC CAC CCC TCT              glutamate dehydrogenase (*gdh*)                KJ499992                188
  GL-MT-R                     Reverse       TGC CTC TGG AGC TCG GTC                                                                                                                                                              
                                                                                                                                                                                                                                 
  *Cyclospora cayetanensis*   CC-MT-F       Forward                                                                  CAT TTG GCT TTA GCC GGC GAT A        18S ribosomal RNA (18S rRNA)                   AB111183                400
  CC-MT-R                     Reverse       N[\*](#tfn1-kjp-54-5-631){ref-type="table-fn"}TA CGG GCA AGG CCG GAT G                                                                                                               

N (A, C, G, T) is used to represent a mixed base code.
